Clinical study of Tirofiban coronary injection preconditioning combined with PCI in the treatment of AMI
Objective To study the clinical effects of Tirofiban coronary injection preconditioning combined with PCI in the treatment of AMI.Methods General data were selected from 80 patients with AMI who received relevant treatment from January 2019 to March 2023,including 40 patients in each group.The control group was treated with PCI,and the observation group was treated with Tirofiban coronary injection preconditioning combined with PCI.The effects of the two groups after treatment were compared.Results After treatment,it was found that the vascular endothelial function of patients in the observation group was superior to that in the control group,and the probability of endothelial hemorrhage was lower than that in the control group,P<0.05,the difference was statistically significant.Conclusion Tirofiban can significantly improve coronary blood flow and myocardial ischemia during PCI in acute infarction,and can effectively protect the vascular endothelia of patients,with good safety.
TirofibanCoronary injection preconditioningCombined PCITreatment of AMI
万方数据
维普
